Cytomegalovirus Retinitis in a Patient with Lupus
Author Information
Author(s): Kelkar Aditya, Kelkar Jai, Kelkar Shreekant, Bhirud Shilpa, Biswas Jyotirmoy
Primary Institution: National Institute of Ophthalmology
Hypothesis
Is cytomegalovirus retinitis a risk for seronegative patients with systemic lupus erythematosus on immunosuppressive therapy?
Conclusion
A combination therapy of intravitreal foscarnet with oral and intravenous ganciclovir is effective for treating clinically resistant CMV retinitis in seronegative patients with SLE.
Supporting Evidence
- The patient had a history of systemic lupus erythematosus and was on immunosuppressive therapy.
- After treatment, the patient's vision improved significantly.
- No recurrences were noted up to 6 months after treatment.
Takeaway
This study talks about a woman with lupus who got a serious eye infection. Doctors used special medicines to help her see better again.
Methodology
The patient was treated with a combination of intravitreal ganciclovir, foscarnet, and systemic ganciclovir after tapering her immunosuppressive therapy.
Participant Demographics
A 31-year-old female with systemic lupus erythematosus.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website